Clinical-based automated delivery of treatment substances to the inner ear
US12070575B2 · kind B2 · utility
0Cited by
3References
30Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 4, 2018 |
| Grant date | Aug 27, 2024 |
| Priority date | — |
| Expiry date | May 8, 2041 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61M2230/08
- WIPO fieldMedical technology
- WIPO sectorInstruments
Abstract
Presented herein are techniques for clinical-based automated control of the delivery of treatment substances to at least one inner ear of a recipient of an implantable medical device. More specifically, in-vivo biomarkers are analyzed to determine a biological state/status of one or more physiological elements of the inner ear. Subsequent delivery of one or more treatment substances to the inner ear of the recipient are controlled based on the determined biological state of the one or more physiological elements of the inner ear.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.